4.54

4.85% 0.21

After Hours: 4.65 0.11 +2.42%

Neuronetics Inc (STIM)

Overview News Price History Option Chain Financials Discussions Forecast

Neuronetics Inc stock is traded at $4.54, with a volume of 1.24M. It is up +4.85% in the last 24 hours and up +15.52% over the past month. Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Previous Close:

$4.33

Open:

$4.5

24h Volume:

1.24M

Relative Volume:

1.01

Market Cap:

$294.55M

Revenue:

$69.23M

Net Income/Loss:

$-33.10M

P/E Ratio:

-3.8475

EPS:

-1.18

Net Cash Flow:

$-39.26M

1W Performance:

-10.28%

1M Performance:

+15.52%

6M Performance:

+511.69%

1Y Performance:

+7.33%

1-Day Range:

$4.29

$4.7795

1-Week Range:

$4.18

$5.92

52-Week Range:

$0.52

$5.92

Neuronetics Inc Stock (STIM) Company Profile

Name

Neuronetics Inc

Sector

Healthcare (1170)

Industry

Diagnostics & Research (60)

Phone

877-600-7555

Address

3222 PHOENIXVILLE PIKE, MALVERN, PA

Employee

201

Twitter

@tmstherapy

Next Earnings Date

2025-03-04

Latest SEC Filings

STIM's Discussions on Twitter

Compare STIM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STIM Neuronetics Inc	4.54	294.55M	69.23M	-33.10M	-39.26M	-1.18
TMO Thermo Fisher Scientific Inc	514.20	193.99B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	205.61	146.95B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	426.69	34.70B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	121.03	34.51B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	183.48	32.35B	15.41B	1.37B	2.11B	7.50

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jul-24-18	Initiated	Canaccord Genuity	Buy

View All

Neuronetics Inc Stock (STIM) Latest News

Mar 09, 2025

Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia

Mar 09, 2025

Mar 08, 2025

Neuronetics (NASDAQ:STIM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World

Mar 07, 2025

Mar 06, 2025

(STIM) Technical Data - Stock Traders Daily

Mar 06, 2025

Neuronetics executive sells shares worth $1,688 By Investing.com - Investing.com Canada

Mar 06, 2025

Neuronetics executive sells shares worth $1,688 - Investing.com India

Mar 06, 2025

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story - Simply Wall St

Mar 06, 2025

Transcranial Magnetic Stimulator Market Growth and Future - openPR

Mar 06, 2025

Mar 05, 2025

Neuronetics’ Earnings Call: Growth Amid Challenges - TipRanks

Mar 05, 2025

Neuronetics Grants Inducement Awards to New Employees - MSN

Mar 05, 2025

Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025

Neuronetics stock holds Market Outperform amid merger growth By Investing.com - Investing.com Canada

Mar 05, 2025